Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
13,290.00    56.00 (0.42%)
Bid:
13,338.00
Ask:
13,344.00
Spread: 6.00 (0.045%)
Market Cap: £206.11b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities
5 May 2026

LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities

(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh
1 May 2026

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh

May 1 (Reuters) - London's blue-chip FTSE 100 closed slightly lower on ​Friday, ‌dragged down by losses in heavyweight energy stocks and drugmaker Ast...

LONDON MARKET CLOSE: Oil price declines amid reports of new Iran offer
1 May 2026

LONDON MARKET CLOSE: Oil price declines amid reports of new Iran offer

(Alliance News) - The FTSE 100 closed down on Friday, but above early lows, while the oil price fell amid reports that Iran has made a new proposal am...

London close: Stocks mixed as investors mull longer Hormuz blockade
1 May 2026

London close: Stocks mixed as investors mull longer Hormuz blockade

(Sharecast News) - London stocks ended mixed on Friday as investors weighed ongoing concerns about the Strait of Hormuz blockade against resilient dom...

AstraZeneca shares dip after US regulatory panel rejects breast cancer drug
1 May 2026

AstraZeneca shares dip after US regulatory panel rejects breast cancer drug

* FDA panel votes against camizestrant over trial design concerns

Mixed outcome for AstraZeneca as US committee votes on cancer drugs
1 May 2026

Mixed outcome for AstraZeneca as US committee votes on cancer drugs

(Alliance News) - AstraZeneca PLC on Friday said it had secured a recommendation for its cancer drug Truqap from US authorities, but failed to secure ...

IN BRIEF: AstraZeneca gets FDA panel nod for Truqap in prostate cancer
1 May 2026

IN BRIEF: AstraZeneca gets FDA panel nod for Truqap in prostate cancer

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Says the US Food & Drug Administration's Oncologic Drugs Advisory Committee recommen...

European shares log biggest monthly gains in over a year
30 Apr 2026

European shares log biggest monthly gains in over a year

* Defense stocks ​lead gains, aided by Rolls-Royce